Intermountain Health Care, Inc.
Clinical trials sponsored by Intermountain Health Care, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- No-Needle blood draw device tested in ER to cut contamination Results expected Oct 2026 (estimated)
- Massive heart study aims to unlock secrets of cardiovascular disease Results expected Mar 2027 (estimated)
- New study aims to cut antibiotic overuse in children with ear infections Results expected Jun 2027 (estimated)
-
Protein blood test aims to personalize heart care, but study stalls
Knowledge-focused Stopped earlyThis study looked at whether a new blood test called SomaSignal could help doctors make better treatment decisions for people at higher risk of heart disease. The test measures proteins in the blood to predict heart risks. Only 12 people took part before the study was stopped ear…
Sponsor: Intermountain Health Care, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Cheap heart scan may replace costly stress tests for chest pain patients
Knowledge-focused Stopped earlyThis study tested whether starting with a low-cost coronary calcium scan (about $100) could safely avoid the need for a more expensive heart stress test (over $1,500) in people with chest pain. Researchers planned to enroll 48 adults aged 50 and older with suspected heart disease…
Sponsor: Intermountain Health Care, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC